01.23.2018 Issue 386

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

Whiteboard Video Offers Co-Pay Solution

Friday, Jan. 19, 2018

A whiteboard video by the University of Michigan’s Value-Based Insurance Design Center offers what it calls a “clinically nuanced solution” to co-pay assistance problems.

U.K.’s NICE Backs Janssen Cancer Drug

Sen. Schumer Names Final Members to Health Committee

Lawsuit: CVS-Aetna Deal Shortchanging Shareholders

Research: Wearable Health Tech Falls Short on Patient Outcomes

German Drug Assessment Watchdog Pushes Direct Comparison of Cancer Immunotherapies

Bringing RWE, RWD to Center Stage

Machine Learning in the Health Industry: Tech Emergence Article Breaks it Down

Looking to Boost Your Freelance Writing on LinkedIn? Check These Tips!


Associate Director, Strategic Market Access- CAR-T

Junior Health Economist, North West England

Senior Research Scientist - HEOR Strategy

Value Communications Director / Senior Market Access Writer, Home Based

Health Economics Manager, Pharma, UK

Senior Account Director

Senior Market Access Writer, Home Based (UK), £70k-£90k

Industry Spotlight



Conferences Webinars

Patients as Partners Europe
    January 23-24, London

CBI’s Reimbursement and Contracting Conference
    January 24-25, Philadelphia

CBI's Data Analytics and Decisions Conference
    January 24-25, Philadelphia

Specialty Therapies — A Forum for Payers
    January 25-26, Las Vegas

Clinical Data Integration for Health Plans: Top 5 Challenges and Solutions
    January 23

Early Access Masterclass: Translate Early Access into Wider Access
    January 25

Real-world Datasets in the United States
    January 26

Big Data and AI: Uncovering New Insights into Fibrotic Disease Progression, Treatments and Outcomes
    January 30


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Market Access Impact: Type 2 Diabetes Mellitus (Injectables) (US) 2017

Market Access Impact: Type 2 Diabetes Mellitus (Orals) (US) 2017

Market Access Impact: Rheumatoid Arthritis (US) 2017

Pricing and Reimbursement in Oncology: Payer views

The ROI of Orphan Drugs: Ensuring Optimal Returns

The State of Digital Identification and Signatures

Secure Document Workflows in Drug Development

Streamline Regulatory Compliance in Life Sciences with Digital Transaction Management

The Paperless Future of Healthcare and Life Sciences

Acquiring Scientific Content: How Hard Can It Be?


Special Thanks to Our Partners:
Curo Pharmerit DRG Abacus eMax Health Evidence PartnersEvidera
eyeforpharma G&J Lee Recruitment HealthCore Jefferson MAPSUniversity of FL
IQVIA      Truven    XcendaOM1Parexel
ICON      Dymaxium